Max Robotics — Global Service Robot Directory + US Certification

About

Masahide Ohmichi is a leading figure in gynecologic oncology, whose research focuses on refining surgical approaches for early-stage cervical and endometrial cancers. His major contributions center on critically evaluating and advancing minimally invasive surgery (MIS). In a pivotal 2022 study, Ohmichi compared MIS to abdominal radical hysterectomy for early-stage cervical cancer, revealing that MIS was associated with higher recurrence and death rates—a finding with 8 citations that has sparked important clinical debate. To address these challenges, he pioneered a novel robot-assisted modified radical hysterectomy that uses indocyanine green (ICG) to remove lymphatic vessels, enhancing surgical precision and safety. His 2024 work further explores oncologic outcomes after sentinel lymph node biopsy in cervical cancer, comparing results to standard lymphadenectomy. With a growing citation impact, Ohmichi’s research directly shapes surgical standards, balancing the benefits of minimally invasive techniques with rigorous oncologic safety. His innovative use of ICG-guided lymphatic mapping represents a notable achievement, offering a pathway to reduce recurrence risks while preserving the advantages of robotic surgery.